{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:30Z","timestamp":1791267150300,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["F.No.33\/3\/2019TF\/Rare\/BMS"],"award-info":[{"award-number":["F.No.33\/3\/2019TF\/Rare\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13346-025-01848-2","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T15:47:32Z","timestamp":1744127252000},"page":"4654-4672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lactoferrin-modified PLGA nanoparticles for pregabalin: development, characterization, in vitro targeting and pharmacodynamic evaluation"],"prefix":"10.1007","volume":"15","author":[{"given":"Garima","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pammi","family":"Gauba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-8996","authenticated-orcid":false,"given":"Shweta","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"10172","key":"1848_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689\u2013701.","journal-title":"Lancet"},{"key":"1848_CR2","unstructured":"WHO website. (https:\/\/www.who.int\/health-topics\/epilepsy#tab=tab_1) last visited on 02.03.2024."},{"issue":"3","key":"1848_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3947","volume":"18","author":"K Staley","year":"2015","unstructured":"Staley K. Molecular mechanisms of epilepsy. Nat Neurosci. 2015;18(3):367\u201372.","journal-title":"Nat Neurosci"},{"issue":"5","key":"1848_CR4","doi-asserted-by":"publisher","first-page":"S514","DOI":"10.1016\/S0929-693X(22)00285-8","volume":"29","author":"M Kuchenbuch","year":"2022","unstructured":"Kuchenbuch M, Chiron C, Milh M. Overview of therapeutic options for epilepsy. Archives De P\u00e9diatrie. 2022;29(5):S514\u20139.","journal-title":"Archives De P\u00e9diatrie"},{"issue":"6","key":"1848_CR5","first-page":"5165","volume":"13","author":"DS Reddy","year":"2020","unstructured":"Reddy DS. Clinical Pharmacology and therapeutics of antiepileptic drugs for the treatment of epilepsy and seizure disorders. Int J Pharm Sci Nanatechnol (IJPSN). 2020;13(6):5165\u201380.","journal-title":"Int J Pharm Sci Nanatechnol (IJPSN)"},{"issue":"1","key":"1848_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11096-023-01657-y","volume":"46","author":"H Xie","year":"2024","unstructured":"Xie H, Zheng Y, Wang C, Song S, Dai Y, Huang X, Liu M, Wu X. Managing delayed or missed Pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study. Int J Clin Pharm. 2024;46(1):150\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"1848_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/07391102.2023.2199874","volume":"42","author":"P Kumar","year":"2024","unstructured":"Kumar P, Sheokand D, Grewal A, Saini V, Kumar A. Clinical side-effects-based drug repositioning for anti-epileptic activity. J Biomol Struct Dynamics. 2024;42(3):1443\u201354.","journal-title":"J Biomol Struct Dynamics"},{"issue":"2","key":"1848_CR8","doi-asserted-by":"publisher","first-page":"101935","DOI":"10.1016\/j.jsps.2023.101935","volume":"32","author":"YS Althobaiti","year":"2024","unstructured":"Althobaiti YS. Oral self-administration of Pregabalin in a mouse model and the resulting drug addiction features. Saudi Pharm J. 2024;32(2):101935.","journal-title":"Saudi Pharm J"},{"issue":"8","key":"1848_CR9","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1016\/j.arabjc.2020.05.010","volume":"13","author":"AW Ajlouni","year":"2020","unstructured":"Ajlouni AW, AlAsiri AM, Adil SF, Shaik MR, Khan M, Assal ME, Kuniyil M, Al-Warthan A. Nanocomposites of gold nanoparticles with Pregabalin: the future anti-seizure drug. Arab J Chem. 2020;13(8):6267\u201373.","journal-title":"Arab J Chem"},{"key":"1848_CR10","doi-asserted-by":"crossref","unstructured":"Shorvon S, Perucca E, Engel J Jr, editors. The treatment of epilepsy. Volume 15. Wiley; 2015 Sep.","DOI":"10.1002\/9781118936979"},{"issue":"1\u20132","key":"1848_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpharm.2018.05.023","volume":"547","author":"A Zybina","year":"2018","unstructured":"Zybina A, Anshakova A, Malinovskaya J, Melnikov P, Baklaushev V, Chekhonin V, Maksimenko O, Titov S, Balabanyan V, Kreuter J, Gelperina S. Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy. Int J Pharm. 2018;547(1\u20132):10\u201323.","journal-title":"Int J Pharm"},{"key":"1848_CR12","unstructured":"Song N, Zhang C, Wang S, Guan Y. Lamotrigine loaded nano-liposomes enhance brain selectivity in vivo. Pak J Pharm Sci. 2021;34(3)."},{"issue":"2","key":"1848_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.15282\/ijets.6.2016.1.9.1059","volume":"3","author":"B Senthilnathan","year":"2016","unstructured":"Senthilnathan B, Maheswaran A, Gopalasatheeskumar K, Masilamani K, Edros RZ. Formulation and evaluation of Pregabalin loaded Eudragit S100 nanoparticles. Int J Eng Technol Sci. 2016;3(2):64\u201370.","journal-title":"Int J Eng Technol Sci"},{"issue":"21","key":"1848_CR14","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.3390\/polym13213837","volume":"13","author":"RF Rodrigues","year":"2021","unstructured":"Rodrigues RF, Nunes JB, Agostini SB, Dos Santos PF, Cancino-Bernardi J, Placido RV, Moraes TR, Freitas JT, Pereira GR, Carvalho FC, Galdino G. Preclinical evaluation of polymeric nanocomposite containing Pregabalin for sustained release as potential therapy for neuropathic pain. Polymers. 2021;13(21):3837.","journal-title":"Polymers"},{"key":"1848_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","volume":"159","author":"M Mir","year":"2017","unstructured":"Mir M, Ahmed N, ur Rehman A. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B: Bio Interfaces. 2017;159:217\u201331.","journal-title":"Colloids Surf B: Bio Interfaces"},{"key":"1848_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1208\/s12249-023-02625-5","volume":"24","author":"S Singh","year":"2023","unstructured":"Singh S, Shukla R. Nanovesicular-Mediated intranasal drug therapy for neurodegenerative disease. AAPS PharmSciTech. 2023;24:179.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"1848_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/17425247.2021.1823965","volume":"18","author":"M Shringarpure","year":"2021","unstructured":"Shringarpure M, Gharat S, Momin M, Omri A. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin Drug Deliv. 2021;18(2):169\u201385.","journal-title":"Expert Opin Drug Deliv"},{"key":"1848_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/cbin.10459","volume":"39","author":"S Salatin","year":"2015","unstructured":"Salatin S, Dizaj SM, Khosroushahi AY. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int. 2015;39:881\u201390. https:\/\/doi.org\/10.1002\/cbin.10459.","journal-title":"Cell Biol Int"},{"issue":"12","key":"1848_CR19","first-page":"1413","volume":"16","author":"MD Cayero-Otero","year":"2019","unstructured":"Cayero-Otero MD, Gomes MJ, Martins C, \u00b4Alvarez-Fuentes J, Fern\u00b4andez- Ar\u00b4evalo M, Sarmento B. Mart\u00edn-Banderas, in vivo biodistribution of venlafaxine- PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles, expert Opin. Drug Deliv. 2019;16(12):1413\u201327.","journal-title":"Drug Deliv"},{"issue":"1","key":"1848_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1080\/21691401.2020.1850465","volume":"48","author":"A Halder","year":"2020","unstructured":"Halder A, Jethwa M, Mukherjee P, Ghosh S, Das S, Helal Uddin AB, Mukherjee A, Chatterji U, Roy P. Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple-negative breast and laryngeal cancer cells. Artif Cells Nanomed Biotechnol. 2020;48(1):1362\u201371.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1848_CR21","volume-title":"Emerging technologies for nanoparticle manufacturing","author":"SA Chaudhary","year":"2021","unstructured":"Chaudhary SA, Patel DM, Patel JK, Patel DH. Solvent emulsification evaporation and solvent emulsification diffusion techniques for nanoparticles. In: Patel JK, Pathak YV, editors. Emerging technologies for nanoparticle manufacturing. Cham: Springer; 2021."},{"issue":"2","key":"1848_CR22","first-page":"295","volume":"11","author":"S Palassi","year":"2021","unstructured":"Palassi S, Valizadeh H, Allahyari S, Zakeri-Milani P. Preparation and in vitro characterization of Enoxaparin nano-liposomes through different methods. Adv Pharm Bull. 2021;11(2):295..%20Advanced%20Pharmaceutical%20Bulletin.%202021%20Feb%3B.","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"1848_CR23","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/ijms22062792","volume":"22","author":"S Ryu","year":"2021","unstructured":"Ryu S, Park S, Lee HY, Lee H, Cho CW, Baek JS. Biodegradable nanoparticles-loaded Plga microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug. Int J Mol Sci. 2021;22(6):2792.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1848_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1208\/s12249-022-02449-9","volume":"23","author":"A Kaur","year":"2022","unstructured":"Kaur A, Nigam K, Tyagi A, Dang S. A preliminary pharmacodynamic study for the management of Alzheimer\u2019s disease using memantine-loaded PLGA nanoparticles. AAPS PharmSciTech. 2022;23(8):298.","journal-title":"AAPS PharmSciTech"},{"key":"1848_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-020-04798-7","volume":"22","author":"LE Scheeren","year":"2020","unstructured":"Scheeren LE, Nogueira-Librelotto DR, Macedo LB, de Vargas JM, Mitjans M, Vinardell MP, Rolim CM. Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy. J Nanopart Res. 2020;22:1\u20138.","journal-title":"J Nanopart Res"},{"key":"1848_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","volume":"14","author":"MI Teixeira","year":"2022","unstructured":"Teixeira MI, Lopes CM, Gon\u00e7alves H, Catita J, Silva AM, Rodrigues F, Amaral MH, Costa PC, Formulation. Characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain. Pharmaceutics. 2022;14:185.","journal-title":"Pharmaceutics"},{"key":"1848_CR27","doi-asserted-by":"crossref","unstructured":"Rai G, Gauba P, Tyagi A, Dang S. Surface modified PLGA nanoparticles of Gabapentin: biodistribution and pharmacodynamic investigation via intranasal route. J Drug Deliv Sci Technol. 2024 May;15:105786.","DOI":"10.1016\/j.jddst.2024.105786"},{"key":"1848_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-10-38","volume":"10","author":"AP Ranjan","year":"2012","unstructured":"Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol. 2012;10:1\u20138.","journal-title":"J Nanobiotechnol"},{"key":"1848_CR29","doi-asserted-by":"crossref","unstructured":"Sharma S, Dang S. Paroxetine loaded PLGA nanoparticles. Materials Today: Proceedings. 2020;28:205\u201310.","DOI":"10.1016\/j.matpr.2020.01.568"},{"issue":"2","key":"1848_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/pharmaceutics14020410","volume":"14","author":"HA Abo El-Enin","year":"2022","unstructured":"Abo El-Enin HA, Mostafa RE, Ahmed MF, Naguib IA, Abdelgawad A, Ghoneim M, Abdou MM. Assessment of nasal-brain-targeting efficiency of newly developed mucoadhesive emulsomes encapsulating an anti-migraine drug for effective treatment of one of the major psychiatric disorders symptoms. Pharmaceutics. 2022;14(2):410.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1848_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","volume":"24","author":"I Singh","year":"2016","unstructured":"Singh I, Swami R, Pooja D, Jeengar MK, Khan W, Sistla R. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 2016;24(3):212\u201323.","journal-title":"J Drug Target"},{"key":"1848_CR32","doi-asserted-by":"publisher","first-page":"119776","DOI":"10.1016\/j.ijpharm.2020.119776","volume":"589","author":"AT Chatzitaki","year":"2020","unstructured":"Chatzitaki AT, Jesus S, Karavasili C, Andreadis D, Fatouros DG, Borges O. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety. Int J Pharm. 2020;589:119776.","journal-title":"Int J Pharm"},{"key":"1848_CR33","doi-asserted-by":"publisher","first-page":"126471","DOI":"10.1016\/j.ijbiomac.2023.126471","volume":"252","author":"S Sharma","year":"2023","unstructured":"Sharma S, Tyagi A, Dang S. Nose to brain delivery of transferrin conjugated PLGA nanoparticles for clonidine. Int J Biol Macromol. 2023;252:126471.","journal-title":"Int J Biol Macromol"},{"key":"1848_CR34","first-page":"e201048","volume":"58","author":"M Rashid","year":"2022","unstructured":"Rashid M, Hussain T, Sarfraz M, Arafat M, Hussain A, Abbas N, Bukhari NI. Precise and sensitive ambient temperature based analytical colorimetric method for Pregabalin. Brazilian J Pharm Sci. 2022;58:e201048.","journal-title":"Brazilian J Pharm Sci"},{"issue":"10","key":"1848_CR35","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.52711\/0974-360X.2021.00888","volume":"14","author":"K Ponnekanti","year":"2021","unstructured":"Ponnekanti K, Sunitha K, Ganapaty S. Development and validation of new RP-HPLC method for simultaneous Estimation of methylcobalamin, Epalrestat and Pregabalin in bulk and pharmaceutical dosage form. Res J Pharm Technol. 2021;14(10):5097\u2013100.","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"1848_CR36","first-page":"482","volume":"3","author":"M Ashu","year":"2011","unstructured":"Ashu M, Parmar S, Nagarajan K, Singh V. Development and validation of rapid HPLC method for determination of Pregabalin in bulk drug and capsule dosage forms. Der Pharma Chem. 2011;3(1):482\u20139.","journal-title":"Der Pharma Chem"},{"issue":"1\u20132","key":"1848_CR37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ijpharm.2014.07.022","volume":"473","author":"T Khuroo","year":"2014","unstructured":"Khuroo T, Verma D, Talegaonkar S, Padhi S, Panda AK, Iqbal Z. Topotecan\u2013tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. Int J Pharm. 2014;473(1\u20132):384\u201394.","journal-title":"Int J Pharm"},{"key":"1848_CR38","doi-asserted-by":"publisher","first-page":"101724","DOI":"10.1016\/j.jddst.2020.101724","volume":"57","author":"KS Shamarekh","year":"2020","unstructured":"Shamarekh KS, Gad HA, Soliman ME, Sammour OA. Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of Tacrine: In-vitro and in-vivo assessment. J Drug Deliv Sci Technol. 2020;57:101724.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"1848_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.xphs.2021.10.034","volume":"111","author":"NK Al-Nemrawi","year":"2022","unstructured":"Al-Nemrawi NK, Altawabeyeh RM, Darweesh RS. Preparation and characterization of docetaxel-PLGA nanoparticles coated with folic acid-chitosan conjugate for cancer treatment. J Pharm Sci. 2022;111(2):485\u201394.","journal-title":"J Pharm Sci"},{"key":"1848_CR40","doi-asserted-by":"publisher","first-page":"110962","DOI":"10.1016\/j.fct.2019.110962","volume":"136","author":"S Sathya","year":"2020","unstructured":"Sathya S, Shanmuganathan B, Balasubramaniam B, Balamurugan K, Devi KP. Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer\u2019s related genes and neuronal apoptosis against amyloid-\u03b2 induced toxicity in Neuro-2a cells and Transgenic caenorhabditis elegans. Food Chem Toxicol. 2020;136:110962.","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"1848_CR41","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3390\/pharmaceutics15082168","volume":"15","author":"X Yao","year":"2023","unstructured":"Yao X, Bunt C, Liu M, Quek SY, Shaw J, Cornish J, Wen J. Enhanced cellular uptake and transport of bovine lactoferrin using pectin-and Chitosan-modified solid lipid nanoparticles. Pharmaceutics. 2023;15(8):2168.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1848_CR42","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1038\/s41598-023-36492-8","volume":"13","author":"EM ElFakharany","year":"2023","unstructured":"ElFakharany EM, AbuSerie MM, Ibrahim A, Eltarahony M. Anticancer activity of lactoferrin-coated biosynthesized selenium nanoparticles for combating different human cancer cells via mediating apoptotic effects. Sci Rep. 2023;13(1):9579.","journal-title":"Sci Rep"},{"issue":"2","key":"1848_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","volume":"19","author":"D Tewari","year":"2021","unstructured":"Tewari D, Sah AN, Bawari S, Nabavi SF, Dehpour AR, Shirooie S, Braidy N, Fiebich BL, Vacca RA, Nabavi SM. Role of nitric oxide in neurodegeneration: function, regulation, and Inhibition. Curr Neuropharmacol. 2021;19(2):114\u201326.","journal-title":"Curr Neuropharmacol"},{"key":"1848_CR44","unstructured":"S\u00e1nchez-Ramos M, Guerrero-Alonso A, Romero-Estrada A, Gonz\u00e1lez-Christen J, Alvarez L, Rom\u00e1n-Guerrero A, Cruz-Sosa F, Marquina-Bahena S. Constituents from Ageratina pichinchensis and Its Inhibitory Effect on Nitric Oxide Production."},{"key":"1848_CR45","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ijbiomac.2019.08.100","volume":"139","author":"SA Ghumman","year":"2019","unstructured":"Ghumman SA, Bashir S, Noreen S, Khan AM, Malik MZ. Taro-corms mucilage-alginate microspheres for the sustained release of Pregabalin: in vitro & in vivo evaluation. Int J Biol Macromol. 2019;139:1191\u2013202.","journal-title":"Int J Biol Macromol"},{"key":"1848_CR46","doi-asserted-by":"publisher","unstructured":"Wilson B, Lavanya Y, Priyadarshini SR, Ramasamy M, Jenita JL. Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies. Int J Pharm. 2014;473(1\u20132):73\u2013\u20099. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.056. Epub 2014 Jul 3. PMID: 24999053.","DOI":"10.1016\/j.ijpharm.2014.05.056"},{"key":"1848_CR47","doi-asserted-by":"publisher","first-page":"120604","DOI":"10.1016\/j.ijpharm.2021.120604","volume":"602","author":"AH Salama","year":"2021","unstructured":"Salama AH, Salama AA, Elhabak M. Single-step nanospray drying Preparation technique of gabapentin-loaded nanoparticles-mediated brain delivery for effective treatment of PTZ-induced seizures. Int J Pharm. 2021;602:120604.","journal-title":"Int J Pharm"},{"issue":"2","key":"1848_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejps.2010.03.007","volume":"40","author":"H Chen","year":"2010","unstructured":"Chen H, Tang L, Qin Y, Yin Y, Tang J, Tang W, Sun X, Zhang Z, Liu J, He Q. Lactoferrin-modified pro cationic liposomes as a novel drug carrier for brain delivery. Eur J Pharm Sci. 2010;40(2):94\u2013102.","journal-title":"Eur J Pharm Sci"},{"key":"1848_CR49","unstructured":"Hutchens TW, L\u00f6nnerdal B, editors. Lactoferrin: interactions and biological functions. Springer Science & Business Media; 2012. Dec 6."},{"issue":"2","key":"1848_CR50","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/ijms14022862","volume":"14","author":"FY Huang","year":"2013","unstructured":"Huang FY, Chen WJ, Lee WY, Lo ST, Lee TW, Lo JM. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. Int J Mol Sci. 2013;14(2):2862\u201374.","journal-title":"Int J Mol Sci"},{"key":"1848_CR51","doi-asserted-by":"publisher","first-page":"104082","DOI":"10.1016\/j.jddst.2022.104082","volume":"79","author":"V Gattani","year":"2023","unstructured":"Gattani V, Dawre S. Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route. J Drug Deliv Sci Technol. 2023;79:104082.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1848_CR52","doi-asserted-by":"publisher","unstructured":"Ono K, Sakai H, Tokunaga S, Sharmin T, Aida TM, Mishima K. Encapsulation of Lactoferrin for Sustained Release Using Particles from Gas-Saturated Solutions Processes. 2021;9(1): 73. https:\/\/doi.org\/10.3390\/pr9010073","DOI":"10.3390\/pr9010073"},{"issue":"1","key":"1848_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1735-5362.305184","volume":"16","author":"H Yasin","year":"2021","unstructured":"Yasin H, Al-Taani B, Salem MS. Preparation and characterization of ethylcellulose microspheres for sustained-release of Pregabalin. Res Pharm Sci. 2021;16(1):1\u20135.","journal-title":"Res Pharm Sci"},{"key":"1848_CR54","doi-asserted-by":"publisher","first-page":"114611","DOI":"10.1016\/j.ejpb.2024.114611","volume":"207","author":"D Kelle","year":"2025","unstructured":"Kelle D, Speth KR, Mart\u00ednez-Negro M, Mail\u00e4nder V, Landfester K, Iyisan B. Effect of protein Corona on drug release behavior of PLGA nanoparticles. Eur J Pharm Biopharm. 2025;207:114611.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1848_CR55","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/10717544.2013.838715","volume":"21","author":"E Ahmadi","year":"2014","unstructured":"Ahmadi E, Dehghannejad N, Hashemikia S, Ghasemnejad M, Tabebordbar H. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. Drug Delivery. 2014;21(3):164\u201372.","journal-title":"Drug Delivery"},{"issue":"2","key":"1848_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.xphs.2018.07.013","volume":"108","author":"D Deepika","year":"2019","unstructured":"Deepika D, Dewangan HK, Maurya L, Singh S. Intranasal drug delivery of Frovatriptan succinate\u2013loaded polymeric nanoparticles for brain targeting. J Pharm Sci. 2019;108(2):851\u20139.","journal-title":"J Pharm Sci"},{"key":"1848_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13346-017-0438-8","volume":"8","author":"L Pan","year":"2018","unstructured":"Pan L, Zhou J, Ju F, Zhu H. Intranasal delivery of \u03b1-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by Premix membrane emulsification. Drug Delivery Translational Res. 2018;8:83\u201396.","journal-title":"Drug Delivery Translational Res"},{"issue":"1","key":"1848_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2008.10.016","volume":"134","author":"K Hu","year":"2009","unstructured":"Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. Lactoferrin-conjugated PEG\u2013PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Controlled Release. 2009;134(1):55\u201361.","journal-title":"J Controlled Release"},{"key":"1848_CR59","doi-asserted-by":"publisher","first-page":"1168408","DOI":"10.3389\/fbioe.2023.1168408","volume":"11","author":"L Li","year":"2023","unstructured":"Li L, Tan L, Zhang Q, Cheng Y, Liu Y, Li R, Hou S. Nose-to-brain delivery of self-assembled curcumin-lactoferrin nanoparticles: characterization, neuroprotective effect and in vivo Pharmacokinetic study. Front Bioeng Biotechnol. 2023;11:1168408.","journal-title":"Front Bioeng Biotechnol"},{"key":"1848_CR60","doi-asserted-by":"publisher","unstructured":"Mazhar F, Malhi SM, Simjee SU. Comparative studies on the effects of clinically used anticonvulsants on the oxidative stress biomarkers in pentylenetetrazole-induced kindling model of epileptogenesis in mice. J Basic Clin Physiol Pharmacol. 2017;28(1):31\u201342. https:\/\/doi.org\/10.1515\/jbcpp-2016-0034. PMID: 27658141.","DOI":"10.1515\/jbcpp-2016-0034"},{"issue":"12","key":"1848_CR61","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","volume":"13","author":"D Lee","year":"2021","unstructured":"Lee D, Minko T. Nanotherapeutics for Nose-to-Brain drug delivery: an approach to bypass the blood brain barrier. Pharmaceutics. 2021;13(12):2049. https:\/\/doi.org\/10.3390\/pharmaceutics13122049. PMID: 34959331; PMCID: PMC8704573.","journal-title":"Pharmaceutics"},{"key":"1848_CR62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","volume":"565","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H. Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges. Int J Pharm. 2019;565:258\u201368. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.032. Epub 2019 May 13. PMID: 31095983.","journal-title":"Int J Pharm"},{"issue":"1","key":"1848_CR63","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/1673-5374.344841","volume":"18","author":"L Wang","year":"2023","unstructured":"Wang L, Zhou BQ, Li YH, Jiang QQ, Cong WH, Chen KJ, Wen XM, Wu ZZ. Lactoferrin modification of Berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer\u2019s disease. Neural Regen Res. 2023;18(1):226\u201332. https:\/\/doi.org\/10.4103\/1673-5374.344841. PMID: 35799547; PMCID: PMC9241388.","journal-title":"Neural Regen Res"},{"key":"1848_CR64","doi-asserted-by":"publisher","unstructured":"Fillebeen C, Descamps L, Dehouck MP, Fenart L, Bena\u00efssa M, Spik G, Cecchelli R, Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem. 1999;274(11):7011-7. https:\/\/doi.org\/10.1074\/jbc.274.11.7011. PMID: 10066755.","DOI":"10.1074\/jbc.274.11.7011"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01848-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01848-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01848-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:00:38Z","timestamp":1763269238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01848-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1848"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01848-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"24 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted by adhering to the National Guidelines for the Care and Use of Laboratory Animals in INMAS, DRDO, New Delhi. We obtained authorization from the Animal Ethical Committee, IAEC, New Delhi, India (INM\/IAEC\/2018\/15Ext02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}